Antioxidants in health, disease and aging

CNS and Neurological Disorders - Drug Targets

Volumn 10, Issue 2, 2011, Pages 192-207

  Obrenovich, Mark E ^a   Li, Yi ^b   Parvathaneni, Kalpana ^c   Yendluri, Bharat B ^c   Palacios, Hector H ^c   Leszek, Jerzy ^d   Aliev, Gjumrakch ^e  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

^e University of Atlanta   (United States)

Author keywords

Aging; Alzheimer disease; Cancer; Carbonyl stress; Cardiovascular disease; Inflammation; Neurodegeneration; Nutrition; Oxidative stress; Polyphenolic antioxidants; Polyphenols; Prevention

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ALUMINUM; ANTHOCYANIN; ANTILIPEMIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA TOCOPHEROL; CATECHIN; CURCUMIN; EPICATECHIN; EPICATECHIN GALLATE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; FLAVONOL; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MERCURY; MEVINOLIN; POLYPHENOL; PROCYANIDIN; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG; VITISIN A; VITISIN B;

AGED; AGING; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; CALORIC RESTRICTION; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CHEMICAL STRUCTURE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA DAMAGE; DRUG TARGETING; ENZYME INHIBITION; GENE MUTATION; GRAPE; HEAD AND NECK CARCINOMA; HEART; HEART PROTECTION; HEAVY METAL POISONING; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIFESPAN; LIFESTYLE; MEMORY; MOLECULARLY TARGETED THERAPY; NEOPLASM; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PARKINSON DISEASE; RED WINE; SQUAMOUS CELL CARCINOMA; TEA;

EID: 79551662910     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152711794480375     Document Type: Article

References (135)

1. Davies, K.J. Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp., 1995, 61, 1-31.
2. Shin, M.H.; Moon, Y.J.; Seo, J.-E.; Lee, Y.; Kim, K.H.; Chung, J.H. Reactive oxygen species produced by NADPH oxidase, xanthine oxidase, and mitochondrial electron transport system mediate heat shock-induced MMP-1 and MMP-9 expression. Free Radic. Biol. Med., 2008, 44(4), 635-645.
3. Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol., 1956, 11(3), 298-300.
4. Kahl, R. Oxidative Stress: Oxidants and Antioxidants. Academic Press: London, 1991, pp. 245-273.
5. Steinhubl, S.R. Why have antioxidants failed in clinical trials? Am. J. Cardiol., 2008, 101(10A), 14D-19D.
6. de la Lastra, C.A.; Villegas, I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans., 2007, 35(Pt 5), 1156-1160.
7. ] Kumamoto, M.; Sonda, T.; Nagayama, K.; Tabata, M. Effects of pH and metal ions on antioxidative activities of catechins. Biosci. Biotechnol. Biochem., 2001, 65(1), 126-132.
8. Ristow, M.; Zarse, K.; Oberbach, A.; Kloting, N.; Birringer, M.; Kiehntopf, M.; Stumvoll, M.; Kahn, C.R.; Bluher, M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA, 2009, 106(21), 8665-8670.
9. Rauca, C.; Wiswedel, I.; Zerbe, R.; Keilhoff, G.; Krug, M. The role of superoxide dismutase and alpha -tocopherol in the development of seizures and kindling induced by pentylenetetrazol - influence of the radical scavenger alpha -phenyl-N-tert-butyl nitrone. Brain Res., 2004, 1009(1, 2), 203-212.
10. Nomura, K.; Imai, H.; Koumura, T.; Arai, M.; Nakagawa, Y. Mitochondrial phospholipid hydroperoxide glutathione peroxidase suppresses apoptosis mediated by a mitochondrial death pathway. J. Biol. Chem., 1999, 274(41), 29294-29302.
11. Reddy, V.P.; Beyaz, A. Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases. Drug Discov. Today, 2006, 11(13 & 14), 646-654.
12. Galati, G.; Sabzevari, O.; Wilson, J.X.; O'Brien, P.J. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology, 2002, 177(1), 91-104.
13. Broillard, R.; George, F. Fougerousse, A. Polyphenols produced during red wine ageing. Biofactors, 1997, 6(4/1997), 403-410.
14. Rahman, I.; Biswas, S.K.; Kirkham, P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol., 2006, 72(11), 1439-1452.
15. Howitz Konrad, T.; Bitterman, K.J.; Cohen, H.Y.; Lamming, D.W.; Lavu, S.; Wood, J.G.; Zipkin, R.E.; Chung, P.; Kisielewski, A.; Zhang, L.-L.; Scherer, B.; Sinclair, D. A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 2003, 425(6954), 191-196.
16. Renaud, S.; Gueguen, R. The French paradox and wine drinking. Novartis Found. Symp., 1998, 216, 208-217; discussion 217-222, 152-158.
17. Nojiri, S.; Daida, H.; Inaba, Y. Antioxidants and cardiovascular disease: still a topic of intrest. Environ. Health Prevent. Med., 2004, 9, 200-213.
18. Jovanovic, S.V.; Steenken, S.; Hara, Y.; Simic, M.G. Reduction potentials of flavonoid and model phenoxyl radicals.Which ring in flavonoids is responsible for antioxidant activity? J. Chem. Soc. Perkin Trans. 2, 1996, (11), 2497-2504.
19. Di Majo, D.; La Guardia, M.; Giammanco, S.; La Neve, L.; Giammanco, M. The antioxidant capacity of red wine in relationship with its polyphenolic constituents. Food Chem., 2008, 111(1), 45-49.
20. Hernandez, T.; Estrella, I.; Duenas, M.; Fernandez de Simon, B.; Cadahia, E. Influence of wood origin in the polyphenolic composition of a Spanish red wine aging in bottle, after storage in barrels of Spanish, French and American oak wood. Eur. Food Res. Technol., 2007, 224(6), 695-705.
21. Mukherjee, S.; Lekli, I.; Gurusamy, N.; Bertelli, A.A.; Das, D.K. Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic. Biol. Med., 2009, 46(5), 573-578.
22. Virgili, M.; Contestabile, A. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett., 2000, 281(2-3), 123-126.
23. Parodi, P.W. The French paradox unmasked: the role of folate. Med. Hypotheses, 1997, 49(4), 313-318.
24. Matthews, N.S.; Peck, K.E.; Mealey, K.L.; Taylor, T.S.; Ray, A.C. Pharmacokinetics and cardiopulmonary effects of guaifenesin in donkeys. J. Vet. Pharmacol. Ther., 1997, 20(6), 442-446.
25. Simonson, M.S.; Wang, Y.; Herman, W.H. Ca2+ channels mediate protein tyrosine kinase activation by endothelin-1. Am. J. Physiol., 1996, 270(Suppl. 5, Pt.2), F790-F797.
26. Corder, R.; Douthwaite, J.A.; Lees, D.M.; Khan, N.Q.; Viseu Dos Santos, A.C.; Wood, E.G.; Carrier, M.J. Endothelin-1 synthesis reduced by red wine. Nature 2001, 414(6866), 863-864.
27. Amin, A.; Buratovich, M. The anti-cancer charm of flavonoids: a cup-of-tea will do! Rec. Pat. Anticancer Drug Discov., 2007, 2(2), 109-117.
28. Wang, H.K.; Bastow, K.F.; Cosentino, L.M.; Lee, K.H. Antitumor agents.166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones. J. Med. Chem., 1996, 39(10), 1975-1980.
29. Singh, V.; Saxena, R.C.; Singh, A.K. A flavonoid out of Tephrosia purpurea extract and its antimicrobial effect. Biomed. Pharmacol. J., 2008, 1(2), 465-468.
30. Wandler, A.; Bruun, J.M.; Nielsen, M.P.; Richelsen, B. Ethanol exerts anti-inflammatory effects in human adipose tissue in vitro. Mol. Cell Endocrinol., 2008, 296(1-2), 26-31.
31. Pai, J.K.; Hankinson, S.E.; Thadhani, R.; Rifai, N.; Pischon, T.; Rimm, E.B. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis, 2006, 186(1), 113-120.
32. Mar, M.H.; Zeisel, S.H. Betaine in wine: answer to the French paradox? Med. Hypotheses, 1999, 53(5), 383-385.
33. Zhu, Q.Y.; Huang, Y.; Chen, Z.Y. Interaction between flavonoids and alpha -tocopherol in human low density lipoprotein. J. Nutr. Biochem., 2000, 11(1), 14-21.
34. Rice-Evans, C. Flavonoid antioxidants. Curr. Med. Chem., 2001, 8(7), 797-807.
35. Chanvitayapongs, S.; Draczynska-Lusiak, B.; Sun, A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport, 1997, 8(6), 1499-1502.
36. Koo, M.; Kim, S.H.; Lee, N.; Yoo, M.Y.; Ryu, S.Y.; Kwon, D.Y.; Kim, Y.S. 3-Hydroxy-3-methylglutaryl-CoA(HMG-CoA) reductase inhibitory effect of Vitis vinifera. Fitoterapia, 2008, 79(3), 204-206.
37. Dimitroulakos, J.; Lorimer, I.A.; Goss, G. Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway. Clin. Cancer Res., 2006, 12(14 Pt 2), 4426s-4431s.
38. Roullet, J.B.; Xue, H.; Pappu, A.S.; Roullet, C.; Holcomb, S.; McCarron, D.A. Mevalonate availability and cardiovascular functions. Proc. Natl. Acad. Sci. USA, 1993, 90(24), 11728-11732.
39. Mantha, A.J.; Hanson, J.E.; Goss, G.; Lagarde, A.E.; Lorimer, I.A.; Dimitroulakos, J. Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor. Clin. Cancer Res., 2005, 11(6), 2398-2407.
40. Mantha, A.J.; McFee, K.E.; Niknejad, N.; Goss, G.; Lorimer, I.A.; Dimitroulakos, J. Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells. J. Cancer Res. Clin. Oncol., 2003, 129(11), 631-641.
41. Sun, A.Y.; Simonyi, A.; Sun, G.Y. The French Paradox and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med., 2002, 32(4), 314-318.
42. Draczynska-Lusiak, B.; Chen, Y.M.; Sun, A.Y. Oxidized lipoproteins activate NF-kappaB binding activity and apoptosis in PC12 cells. Neuroreport, 1998, 9(3), 527-532.
43. Schlachterman, A.; Valle, F.; Wall, K.M.; Azios, N.G.; Castillo, L.; Morell, L.; Washington, A.V.; Cubano, L.A.; Dharmawardhane, S.F. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl. Oncol., 2008, 1(1), 19-27.
44. Obrenovich, M.E.; Raina, A.K.; Ogawa, O.A.; Craig, S.; Morelli, L.; Smith, M.A. Alzheimer Disease-A New Beginning, or a Final Exit? Springer, 2005.
45. Ogawa, O.; Zhu, X.; Lee, H.G.; Raina, A.; Obrenovich, M.E.; Bowser, R.; Ghanbari, H.A.; Castellani, R.J.; Perry, G.; Smith, M.A. Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol., 2003, 105(5), 524-528.
46. Rigolio, R.; Miloso, M.; Nicolini, G.; Villa, D.; Scuteri, A.; Simone, M.; Tredici, G. Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxelinduced apoptosis. Neurochem. Int., 2005, 46(3), 205-211.
47. Westerheide, S.D.; Anckar, J.; Stevens, S.M. Jr.; Sistonen, L.; Morimoto, R.I. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science, 2009, 323(5917), 1063-1066.
48. Hyun, D.H.; Hernandez, J.O.; Mattson, M.P.; de Cabo, R. The plasma membrane redox system in aging. Ageing Res. Rev., 2006, 5(2), 209-220.
49. Singh, U.P.; Singh, N.; Singh, B.; Hofseth, L.J.; Price, B.L.; Nagarkatti, M.; Nagarkatti, P. Resveratrol(trans-3, 5, 4'-trihydroxystilbene) induces SIRT1 and down-regulates NF- {kappa}B activation to abrogate DSS-induced colitis. J. Pharmacol. Exp. Ther., 2010, 332(3), 829-839.
50. Baur, J.A.; Pearson, K.J.; Price, N.L.; Jamieson, H.A.; Lerin, C.; Kalra, A.; Prabhu, V.V.; Allard, J.S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P.J.; Poosala, S.; Becker, K.G.; Boss, O.; Gwinn, D.; Wang, M.; Ramaswamy, S.; Fishbein, K.W.; Spencer, R.G.; Lakatta, E.G.; Le Couteur, D.; Shaw, R.J.; Navas, P.; Puigserver, P.; Ingram, D.K.; de Cabo, R.; Sinclair, D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006, 444(7117), 337-342.
51. Anekonda, T.S.; Reddy, P.H. Neuronal protection by sirtuins in Alzheimer's disease. J. Neurochem., 2006, 96(2), 305-313.
52. Calabrese, V.; Scapagnini, G.; Colombrita, C.; Ravagna, A.; Pennisi, G.; Giuffrida Stella, A.M.; Galli, F.; Butterfield, D.A. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids, 2003, 25(3-4), 437-444.
53. Domingo, J.L. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. J. Alzheimers Dis., 2006, 10(2-3), 331-341.
54. Clarkson, T.W. Metal toxicity in the central nervous system. Environ Health Perspect., 1987, 75, 59-64.
55. Mandel, S.; Weinreb, O.; Amit, T.; Youdim, M.B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol(-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem., 2004, 88(6), 1555-1569.
56. Kocisko, D.A.; Baron, G.S.; Rubenstein, R.; Chen, J.; Kuizon, S.; Caughey, B. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol., 2003, 77(19), 10288-10294.
57. Lee, J.; Seroogy, K.B.; Mattson, M.P. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J. Neurochem., 2002, 80(3), 539-547.
58. Shimizu, T.; Shirasawa, T. Anti-aging effects by caloric restriction. Nippon Rinsho., 2009, 67(7), 1366-1371.
59. Aliev, G.; Seyidova, D.; Lamb, B.T.; Obrenovich, M.E.; Siedlak, S.L.; Vinters, H.V.; Friedland, R.P.; LaManna, J.C.; Smith, M.A.; Perry, G. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol. Res., 2003, 25(6), 665-674.
60. Schroeter, H.; Heiss, C.; Balzer, J.; Kleinbongard, P.; Keen, C.L.; Hollenberg, N.K.; Sies, H.; Kwik-Uribe, C.; Schmitz, H.H.; Kelm, M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA, 2006, 103(4), 1024-1029.
61. Raval, A.P.; Lin, H.W.; Dave, K.R.; Defazio, R.A.; Della Morte, D.; Kim, E.J.; Perez-Pinzon, M.A. Resveratrol and ischemic preconditioning in the brain. Curr. Med. Chem., 2008, 15(15), 1545-1551.
62. Joseph, J.A.; Shukitt-Hale, B.; Denisova, N.A.; Bielinski, D.; Martin, A.; McEwen, J.J.; Bickford, P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci., 1999, 19(18), 8114-8121.
63. Haque, A.M.; Hashimoto, M.; Katakura, M.; Tanabe, Y.; Hara, Y.; Shido, O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J. Nutr., 2006, 136(4), 1043-1047.
64. van Praag, H.; Lucero, M.J.; Yeo, G.W.; Stecker, K.; Heivand, N.; Zhao, C.; Yip, E.; Afanador, M.; Schroeter, H.; Hammerstone, J.; Gage, F.H. Plant-derived flavanol(-)epicatechin enhances angiogenesis and retention of spatial memory in mice. J. Neurosci., 2007, 27(22), 5869-5878.
65. Obrenovich, M.E.; Smith, M.A.; Siedlak, S.L.; Chen, S.G.; de la Torre, J.C.; Perry, G.; Aliev, G. Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotox Res., 2006, 10(1), 43-56.
66. Fukuda, S.; Kaga, S.; Zhan, L.; Bagchi, D.; Das, D.K.; Bertelli, A.; Maulik, N. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem. Biophys., 2006, 44(1), 43-49.
67. Srivastava, R.K.; Unterman, T.G.; Shankar, S. FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol. Cell Biochem., 2010, 337(1-2), 201-212.
68. Pearson, K.J.; Baur, J.A.; Lewis, K.N.; Peshkin, L.; Price, N.L.; Labinskyy, N.; Swindell, W.R.; Kamara, D.; Minor, R.K.; Perez, E.; Jamieson, H.A.; Zhang, Y.; Dunn, S.R.; Sharma, K.; Pleshko, N.; Woollett, L.A.; Csiszar, A.; Ikeno, Y.; Le Couteur, D.; Elliott, P.J.; Becker, K.G.; Navas, P.; Ingram, D.K.; Wolf, N.S.; Ungvari, Z.; Sinclair, D.A.; de Cabo, R. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab., 2008, 8(2), 157-168.
69. Chen, J.; Shi, J.; MacNaughton, L.; Kakuda, Y.; Xue, S.J.; Ma, Y.; Zhang, M.; Jiang, Y. The scavenging capacity of combinations of lycopene, beta -carotene, vitamin E, and vitamin C on the free radical 2,2-diphenyl-1-picrylhydrazyl(DPPH). J. Food Biochem.,2009, 33(2), 232-245.
70. Ak, T.; Gülcin, I. Antioxidant and radical scavenging properties of curcumin. Chem.Biol. Interact., 2008, 174, 27-37.
71. Gonzales, A.M.; Orlando, R.A. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr. Metab.(Lond.), 2008, 5, 17.
72. Szewczuk, L.M.; Forti, L.; Stivala, L.A.; Penning, T.M. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J. Biol. Chem., 2004, 279(21), 22727-22737.
73. Mao, T.K.; van de Water, J.; Keen, C.L.; Schmitz, H.H.; Gershwin, M.E. Modulation of TNF-alpha secretion in peripheral blood mononuclear cells by cocoa flavanols and procyanidins. Dev.Immunol., 2002, 9(3), 135-141.
74. Monagas, M.; Quintanilla-Lopez, J.E.; Gomez-Cordoves, C.; Bartolome, B.; Lebron-Aguilar, R. MALDI-TOF MS analysis of plant proanthocyanidins. J. Pharm. Biomed. Anal., 2009, 51(2), 358-372.
75. Torres, J.L.; Lozano, C.; Julia, L.; Sanchez-Baeza, F.J.; Anglada, J.M.; Centelles, J.J.; Cascante, M. Cysteinyl-flavan-3-ol conjugates from grape procyanidins.Antioxidant and antiproliferative properties. Bioorg. Med. Chem., 2002, 10(8), 2497-2509.
76. Salah, N.; Miller, N.J.; Paganga, G.; Tijburg, L.; Bolwell, G.P.; Rice-Evans, C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys., 1995, 322(2), 339-346.
77. Kawai, K.; Tsuno, N.H.; Kitayama, J.; Okaji, Y.; Yazawa, K.; Asakage, M.; Hori, N.; Watanabe, T.; Takahashi, K.; Nagawa, H. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J Allergy Clin. Immunol., 2003, 112(5), 951-957.
78. Fujii, H.; Nakagawa, T.; Nishioka, H.; Sato, E.; Hirose, A.; Ueno, Y.; Sun, B.; Yokozawa, T.; Nonaka, G. Preparation, characterization, and antioxidative effects of oligomeric proanthocyanidin-L-cysteine complexes. J. Agric. Food Chem., 2007, 55, 1525-1531.
79. Stapleton, P.D.; Shah, S.; Anderson, J.C.; Hara, Y.; Hamilton-Miller, J.M.; Taylor, P.W. Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. Antimicrob. Agents, 2004, 23(5), 462-467.
80. Nance, C.L.; Shearer, W.T. Is green tea good for HIV-1 infection? J. Allergy Clin. Immunol., 2003, 112(5), 851-853.
81. Pfeffer, U.; Ferrari, N.; Morini, M.; Benelli, R.; Noonan, D.M.; Albini, A. Antiangiogenic activity of chemopreventive drugs. Int. J. Biol. Markers, 2003, 18(1), 70-74.
82. Katiyar, S.K.; Ahmad, N.; Mukhtar, H. Green tea and skin. Arch. Dermatol., 2000, 136(8), 989-994.
83. Yang, Y.T.; Weng, C.J.; Ho, C.T.; Yen, G.C. Resveratrol analog- 3,5,4'-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Mol. Nutr. Food Res., 2009, 53(3), 407-416.
84. Yuan, H.; Gong, A.; Young, C.Y. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells. Carcinogenesis, 2005, 26(4), 793-801.
85. Cui, Y.; Morgenstern, H.; Greenland, S.; Tashkin, D.P.; Mao, J.T.; Cai, L.; Cozen, W.; Mack, T.M.; Lu, Q.Y.; Zhang, Z.F. Dietary flavonoid intake and lung cancer--a population-based case-control study. Cancer, 2008, 112(10), 2241-2248.
86. Hakim, I.A.; Harris, R.B.; Brown, S.; Chow, H.H.; Wiseman, S.; Agarwal, S.; Talbot, W. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J. Nutr., 2003, 133(10), 3303S-3309S.
87. Esposito, E.; Rotilio, D.; Di Matteo, V.; Di Giulio, C.; Cacchio, M.; Algeri, S. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol. Aging, 2002, 23(5), 719-735.
88. Dona, M.; Dell'Aica, I.; Calabrese, F.; Benelli, R.; Morini, M.; Albini, A.; Garbisa, S. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol., 2003, 170(8), 4335-4341.
89. Rice-Evans, C. Plant polyphenols: free radical scavengers or chainbreaking antioxidants? Biochem. Soc. Symp., 1995, 61, 103-116.
90. Yang, T.T.; Koo, M.W. Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci., 2000, 66(5), 411-423.
91. Chyu, K.Y.; Babbidge, S.M.; Zhao, X.; Dandillaya, R.; Rietveld, A.G.; Yano, J.; Dimayuga, P.; Cercek, B.; Shah, P.K. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation, 2004, 109(20), 2448-2453.
92. Yang, Y.C.; Lu, F.H.; Wu, J.S.; Wu, C.H.; Chang, C.J. The protective effect of habitual tea consumption on hypertension. Arch. Int. Med., 2004, 164(14), 1534-1540.
93. Wu, L.Y.; Juan, C.C.; Ho, L.T.; Hsu, Y.P.; Hwang, L.S. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J. Agric. Food Chem., 2004, 52(3), 643-648.
94. Tian, W.X.; Li, L.C.; Wu, X.D.; Chen, C.C. Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase. Life Sci., 2004, 74(19), 2389-2399.
95. Schroeder, E.K.; Kelsey, N.A.; Doyle, J.; Breed, E.; Bouchard, R.J.; Loucks, F.A.; Harbison, R.A.; Linseman, D.A. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid. Redox Signal., 2009, 11(3), 469-480.
96. Rutter, K.; Sell, D.R.; Fraser, N.; Obrenovich, M.; Zito, M.; Starke-Reed, P.; Monnier, V.M. Green tea extract suppresses the agerelated increase in collagen crosslinking and fluorescent products in C57BL/6 mice. Int. J. Vitam Nutr. Res., 2003, 73(6), 453-460.
97. Mustata, G.T.; Rosca, M.; Biemel, K.M.; Reihl, O.; Smith, M.A.; Viswanathan, A.; Strauch, C.; Du, Y.; Tang, J.; Kern, T.S.; Lederer, M.O.; Brownlee, M.; Weiss, M.F.; Monnier, V.M. Paradoxical effects of green tea(Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes, 2005, 54(2), 517-526.
98. Marel, A.K.; Lizard, G.; Izard, J.C.; Latruffe, N.; Delmas, D. Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells. Mol. Nutr. Food Res., 2008, 52(5), 538-548.
99. Barjot, C.; Tournaire, M.; Castagnino, C.; Vigor, C.; Vercauteren, J.; Rossi, J.F. Evaluation of antitumor effects of two vine stalk oligomers of resveratrol on a panel of lymphoid and myeloid cell lines: comparison with resveratrol. Life Sci., 2007, 81(23-24), 1565-1574.
100. Ha do, T.; Chen, Q.C.; Hung, T.M.; Youn, U.J.; Ngoc, T.M.; Thuong, P.T.; Kim, H.J.; Seong, Y.H.; Min, B.S.; Bae, K. Stilbenes and oligostilbenes from leaf and stem of Vitis amurensis and their cytotoxic activity. Arch. Pharm. Res., 2009, 32(2), 177-183.
101. Colin, D.; Gimazane, A.; Lizard, G.; Izard, J.C.; Solary, E.; Latruffe, N.; Delmas, D. Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells. Int. J. Cancer, 2009, 124(12), 2780-2788.
102. Seya, K.; Kanemaru, K.; Sugimoto, C.; Suzuki, M.; Takeo, T.; Motomura, S.; Kitahara, H.; Niwa, M.; Oshima, Y.; Furukawa, K. Opposite effects of two resveratrol(trans-3,5,4'-trihydroxystilbene) tetramers, vitisin A and hopeaphenol, on apoptosis of myocytes isolated from adult rat heart. J. Pharmacol. Exp. Ther., 2009, 328(1), 90-98.
103. Choi, Y.H.; Yoo, M.Y.; Choi, C.W.; Cha, M.R.; Yon, G.H.; Kwon, D.Y.; Kim, Y.S.; Park, W.K.; Ryu, S.Y. A new specific BACE-1 inhibitor from the stembark extract of Vitis vinifera. Planta Med., 2009, 75(5), 537-540.
104. Scalbert, A.; Deprez, S.; Mila, I.; Albrecht, A.M.; Huneau, J.F.; Rabot, S. Proanthocyanidins and human health: systemic effects and local effects in the gut. Biofactors, 2000, 13(1-4), 115-120.
105. Hurrell, R.F.; Finot, P.A. Nutritional consequences of the reactions between proteins and oxidized polyphenolic acids. Adv. Exp. Med. Biol., 1984, 177, 423-435.
106. Waghorn, G.C.; McNabb, W.C. Consequences of plant phenolic compounds for productivity and health of ruminants. Proc. Nutr. Soc., 2003, 62(2), 383-392.
107. Pierpoint, W.S. Flavonoids in Human Food and Animal Feedstuffs: Amounts and Consequences. National University of Singapore: Singapore, 1990; Vol. Current Issues in Flavonoid Research.
108. Lu, Y.; Bennick, A. Interaction of tannin with human salivary proline-rich proteins. Arch. Oral Biol., 1998, 43(9), 717-728.
109. Chung, K.T.; Lu, Z.; Chou, M.W. Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. Food Chem. Toxicol., 1998, 36(12), 1053-1060.
110. Yan, Q.; Bennick, A. Identification of histatins as tannin-binding proteins in human saliva. Biochem. J., 1995, 311(Pt 1), 341-347.
111. Riedl, K.M.; Hagerman, A.E. Tannin-protein complexes as radical scavengers and radical sinks. J. Agric. Food Chem., 2001, 49(10), 4917-4923.
112. Bittner, S. When quinones meet amino acids: chemical, physical and biological consequences. Amino Acids, 2006, 30(3), 205-224.
113. Wititsuwannakul, D.; Chareonthiphakorn, N.; Pace, M.; Wititsuwannakul, R. Polyphenol oxidases from latex of Hevea brasiliensis: purification and characterization. Phytochemistry, 2002, 61(2), 115-121.
114. Sommer, A.; Ne'eman, E.; Steffens, J.C.; Mayer, A.M.; Harel, E. Import, targeting, and processing of a plant polyphenol oxidase. Plant Physiol., 1994, 105(4), 1301-1311.
115. Chandra, R.; Bharagava, R.N.; Rai, V. Melanoidins as major colourant in sugarcane molasses based distillery effluent and its degradation. Bioresour. Technol., 2008, 99(11), 4648-4660.
116. Dworschak, E. Nonenzyme browning and its effect on protein nutrition. Crit. Rev. Food Sci. Nutr., 1980, 13(1), 1-40.
117. Sell, D.R.; Lane, M.A.; Obrenovich, M.E.; Mattison, J.A.; Handy, A.; Ingram, D.K.; Cutler, R.G.; Roth, G.S.; Monnier, V.M. The effect of caloric restriction on glycation and glycoxidation in skin collagen of nonhuman primates. J. Gerontol. A Biol. Sci. Med. Sci., 2003, 58(6), 508-516.
118. Saito, S.; Kurakane, S.; Seki, M.; Takai, E.; Kasai, T.; Kawabata, J. Radical scavenging activity of dicaffeoyloxycyclohexanes: contribution of an intramolecular interaction of two caffeoyl residues. Bioorg. Med. Chem., 2005, 13(13), 4191-4199.
119. Hurrell, R.F.; Finot, P.A. Food processing and storage as a determinant of protein and amino acid availability. Experientia Suppl., 1983, 44, 135-156.
120. Shahkhalili, Y.; Finot, P.A.; Hurrell, R.; Fern, E. Effects of foods rich in polyphenols on nitrogen excretion in rats. J. Nutr., 1990, 120(4), 346-352.
121. Hagerman, A.E.; Klucher, K.M. Tannin-protein interactions. Prog. Clin. Biol. Res., 1986, 213, 67-76.
122. Bojko, M.; Kruk, J.; Wieckowski, S. Plastoquinones are effectively reduced by ferredoxin:NADP+ oxidoreductase in the presence of sodium cholate micelles.Significance for cyclic electron transport and chlororespiration. Phytochemistry, 2003, 64(6), 1055-1060.
123. Hurrell, R.F.; Finot, P.A.; Cuq, J.L. Protein-polyphenol reactions.1.Nutritional and metabolic consequences of the reaction between oxidized caffeic acid and the lysine residues of casein. Br. J. Nutr., 1982, 47(2), 191-211.
124. Vella, F.; Ferry, G.; Delagrange, P.; Boutin, J.A. NRH:quinine reductase 2: an enzyme of surprises and mysteries. Biochem. Pharmacol., 2005, 71(1-2), 1-12.
125. Wosilait, W.D.; Nason, A. Pyridine nucleotide-quinone reductase.I.Purification and properties of the enzyme from pea seeds. J. Biol. Chem., 1954, 206(1), 255-270.
126. Guo, M.; Perez, C.; Wei, Y.; Rapoza, E.; Su, G.; Bou-Abdallah, F.; Chasteen, N.D. Iron-binding properties of plant phenolics and cranberry's bio-effects. Dalton Trans., 2007, 43, 4951-4961.
127. Boato, F.; Wortley, G.M.; Liu, R.H.; Glahn, R.P. Red grape juice inhibits iron availability: application of an in vitro digestion/caco-2 cell model. J. Agric. Food Chem., 2002, 50(23), 6935-6938.
128. Jonas, C.R.; Ziegler, T.R.; Gu, L.H.; Jones, D.P. Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma(Caco2) cell line. Free Radic. Biol. Med., 2002, 33(11), 1499-1506.
129. Abd El Mohsen, M.M.; Kuhnle, G.; Rechner, A.R.; Schroeter, H.; Rose, S.; Jenner, P.; Rice-Evans, C.A. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic. Biol. Med., 2002, 33(12), 1693-1702.
130. Snipes, W.; Persosn S.; Keith, A.; Cupp J. Butylated hydroxytoluene inactivates lipid-containing viruses. Science 1975, 188(4183), 64-66.
131. Richards, J.T.; Katz, M.E.; Kern, E.R. Topical butylated hydroxytoluene treatment of genital herpes simplex virus infections of guinea pigs. Antiviral Res.,1985, 5(5), 281-290.
132. Kim, K.S.; Moon, H.M. Inactivation of cytomegalovirus and Semliki Forest virus by butylated hydroxytoluene. J. Infect. Dis., 1978, 138(1), 91-94.
133. Shigeoka, S.; Takeda, T.; Hanaoka, T. Characterization and immunological properties of selenium-containing glutathione peroxidase induced by selenite in Chlamydomonas reinhardtii. Biochem. J., 1991, 275(Pt 3), 623-627.
134. Burton, G.W.; Ingold, K.U. Autoxidation of biological molecules. 1. Antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J. Am. Chem. Soc., 1981, 103(21), 6472-6477.
135. Conning, D.M.; Phillips, J.C. Comparative metabolism of BHA, BHT and other phenolic antioxidants and its toxicological relevance. Food Chem. Toxicol., 1986, 24(10-11), 1145-1148.